Drug Type Fusion protein |
Synonyms GPVI-CD39 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingEarly Phase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Coronary Disease | Phase 1 | DE | 24 Sep 2021 | |
Stroke | Phase 1 | DE | 24 Sep 2021 |